Prostate treatment registry aims to find best options for men with BPH
NCT ID NCT07242807
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a large registry that will follow 2,000 men with enlarged prostate (BPH) who receive minimally invasive treatments like Rezum, UroLift, or Aquablation. Researchers will track symptoms, urine flow, and quality of life for up to 6 years to see which treatments work best and for whom. The goal is to provide real-world evidence to guide doctors and patients in choosing the right procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could help doctors choose the best minimally invasive prostate treatment for each patient, improving symptom relief and quality of life.
What could go wrong
This is an observational study, not a treatment trial. It collects data without testing new therapies, so it won't directly lead to a new cure or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA (BPH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Necmettin Erbakan University Medical Faculty Hospital
Konya, 42250, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••